vs
通用电气医疗(GEHC)与飞利浦(PHG)财务数据对比。点击上方公司名可切换其他公司
通用电气医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业,旗下设四大业务板块:医学影像(含分子成像、CT、核磁共振、女性健康筛查、X射线系统)、超声、患者护理解决方案(聚焦远程患者监测、麻醉呼吸护理、心脏病诊断、婴幼儿照护)及制药诊断业务。
皇家飞利浦是一家总部位于荷兰的全球领先健康科技企业,业务覆盖诊断成像、患者监护、个人健康护理、家用医疗设备等多个领域,为全球上百个国家的消费者、医疗机构及企业客户提供创新产品与解决方案。
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
GEHC
PHG
| Q4 25 | $5.7B | — | ||
| Q3 25 | $5.1B | — | ||
| Q2 25 | $5.0B | — | ||
| Q1 25 | $4.8B | — | ||
| Q4 24 | $5.3B | — | ||
| Q3 24 | $4.9B | — | ||
| Q2 24 | $4.8B | — | ||
| Q1 24 | $4.7B | — |
净利润
GEHC
PHG
| Q4 25 | $588.0M | — | ||
| Q3 25 | $446.0M | — | ||
| Q2 25 | $486.0M | — | ||
| Q1 25 | $564.0M | — | ||
| Q4 24 | $721.0M | — | ||
| Q3 24 | $470.0M | — | ||
| Q2 24 | $428.0M | — | ||
| Q1 24 | $374.0M | — |
毛利率
GEHC
PHG
| Q4 25 | 39.7% | — | ||
| Q3 25 | 38.7% | — | ||
| Q2 25 | 39.6% | — | ||
| Q1 25 | 42.1% | — | ||
| Q4 24 | 42.8% | — | ||
| Q3 24 | 41.7% | — | ||
| Q2 24 | 41.4% | — | ||
| Q1 24 | 40.9% | — |
营业利润率
GEHC
PHG
| Q4 25 | 14.5% | — | ||
| Q3 25 | 12.7% | — | ||
| Q2 25 | 13.1% | — | ||
| Q1 25 | 13.2% | — | ||
| Q4 24 | 15.1% | — | ||
| Q3 24 | 13.9% | — | ||
| Q2 24 | 12.6% | — | ||
| Q1 24 | 11.6% | — |
净利率
GEHC
PHG
| Q4 25 | 10.3% | — | ||
| Q3 25 | 8.7% | — | ||
| Q2 25 | 9.7% | — | ||
| Q1 25 | 11.8% | — | ||
| Q4 24 | 13.6% | — | ||
| Q3 24 | 9.7% | — | ||
| Q2 24 | 8.8% | — | ||
| Q1 24 | 8.0% | — |
每股收益(稀释后)
GEHC
PHG
| Q4 25 | $1.28 | — | ||
| Q3 25 | $0.98 | — | ||
| Q2 25 | $1.06 | — | ||
| Q1 25 | $1.23 | — | ||
| Q4 24 | $1.58 | — | ||
| Q3 24 | $1.02 | — | ||
| Q2 24 | $0.93 | — | ||
| Q1 24 | $0.81 | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图